| GO Term | Fold Change | Genes |
| apoptosome | 552.30 | APAF1,CASP9 |
| RecQ family helicase-topoisomerase III complex | 368.20 | RMI2,RMI1 |
| glial cell apoptotic process | 276.15 | TP53,CASP9 |
| flavin-containing compound metabolic process | 220.92 | RFK,SLC52A2 |
| intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 66.95 | BAK1,TP53,APAF1,PML |
| positive regulation of mitochondrial membrane permeability | 59.18 | BAK1,TP53,VDAC2 |
| positive regulation of membrane permeability | 53.45 | BAK1,TP53,VDAC2 |
| intrinsic apoptotic signaling pathway in response to DNA damage | 31.12 | BAK1,TP53,CASP9,PML |
| intrinsic apoptotic signaling pathway | 17.26 | BAK1,TP53,APAF1,CASP9,PML |
| response to endoplasmic reticulum stress | 14.73 | BAK1,TP53,APAF1,UBQLN1,FAF2,PML |
| apoptotic signaling pathway | 10.76 | BAK1,TP53,APAF1,CASP9,VDAC2,PML |
| ubiquitin-dependent protein catabolic process | 9.73 | PLAA,UBQLN1,FAF2,PML,FBXO11,BAP1,PCBP2,UHRF1,UBE2K |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 9.61 | PLAA,UBQLN1,FAF2,PML,PCBP2,UBE2K |
| modification-dependent protein catabolic process | 9.54 | PLAA,UBQLN1,FAF2,PML,FBXO11,BAP1,PCBP2,UHRF1,UBE2K |
| modification-dependent macromolecule catabolic process | 9.34 | PLAA,UBQLN1,FAF2,PML,FBXO11,BAP1,PCBP2,UHRF1,UBE2K |
| proteolysis involved in protein catabolic process | 8.53 | PLAA,UBQLN1,FAF2,PML,FBXO11,BAP1,PCBP2,UHRF1,UBE2K |
| protein catabolic process | 7.15 | PLAA,UBQLN1,FAF2,PML,FBXO11,BAP1,PCBP2,UHRF1,UBE2K |
| DNA damage response | 6.21 | BAK1,TP53,SLFN11,RMI2,CASP9,RMI1,PML,UHRF1 |
| macromolecule catabolic process | 5.39 | PLAA,UBQLN1,FAF2,PML,FBXO11,BAP1,PCBP2,UHRF1,UBE2K |